A recall was extended this week for supplements containing hyaluronic acid.

Hyaluronic acid supplement recall overview: 

• Who: The U.S. Food & Drug Administration has published a recall notice for all lots of Umary Acido Hialuronico, Suplemento Alimenticio/Hyaluronic Acid Dietary Supplement made by Main Products.
• Why: The supplements may be tainted with diclofenac and omeprazole.
• Where: The hyaluronic acid supplement recall is active in the United States. 

A recall was extended this week for supplements containing hyaluronic acid.

In a recall notice published July 22 on the United States Food and Drug Administration (FDA) website, Main Products Inc. announced that it is recalling all lots of its Umary Acido Hialuronico, Suplemento Alimenticio/Hyaluronic Acid Dietary Supplement. 

According to the recall, the product may be “tainted with the drug ingredients” diclofenac and omeprazole, according to an FDA laboratory analysis.

“Products containing diclofenac and omeprazole cannot be marketed as dietary supplements,” the notice says. “Umary is an unapproved new drug for which safety and efficacy have not been established and, therefore, subject to recall.”

The recalled bottles contain 30 tablets with 850 mg strength. The supplements were sold to treat pain and were distributed online via Main Products Inc. on Amazon.

The company is not currently facing a class action lawsuit, but Top Class Actions follows recalls closely as they sometimes result in legal action.

Hidden ingredients can harm consumers

Omeprazole is a proton pump inhibitor that is used to treat stomach acid-related disorders. The drug can cause different conditions, including “serious skin reactions, abdominal pain, diarrhea, nausea, and headache,” the recall says.

“This hidden ingredient may mask stomach issues such as erosions, ulcers, and stomach cancer, and it can also interact with other medications and should not be taken with certain medications,” the recall continues.

Diclofenac belongs to the class of drugs called non-steroidal anti-inflammatory drugs (NSAIDs), the FDA states.

“There is a reasonable probability that consumption of high levels of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as Warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses,” the recall warns.

Recall is extension of one from July 15

This recall follows a previous FDA recall from July 15 that applied to the same Umary supplements distributed online by SoloVital.com.

Main Products is contacting customers to arrange for the return of recalled products. In the meantime, stop using them and either return them to Amazon or mail them to the address provided in the recall notice.

Meanwhile, Bath & Body Works is currently facing a class action lawsuit filed by a customer who alleges the company misrepresents the benefits of hyaluronic acid in its products. 

Peter Thomas Ross is also being sued by consumers who allege in a skincare class action lawsuit that the company’s “Water Drench” line of products is misrepresented. According to the plaintiffs, Peter Thomas Roth falsely states that the presence of hyaluronic acid in the products will “draw moisture from the atmosphere into the user’s skin” and provide hydration for up to 72 hours.

Are you affected by this hyaluronic acid supplement recall? Let us know in the comments.

Read About More Class Action Lawsuits & Class Action Settlements:

• Fish oil supplements do not benefit heart health, class action claims
• Miracle Moo class action lawsuit alleges co. falsely advertises supplements
• Zenwise does not treat gas, bloating as advertised, class action claims
• Emergen-C class action claims product falsely advertised as natural